SLN (silence-therapeutics.com) Prakiraan wutah bathi kanggo taun ngarep

Logo perusahaan publik Silence Therapeutics (SLN)

The expert management of Silence Therapeutics (SLN) is effectively implementing the GOLD platform for targeted siRNA delivery to the liver, developing drugs to treat rare blood pathologies. A promising growth vector for EPS estimates visualizes the synergy between the scientific foundation and market expectations, where -53.00 serves as the final level marker. Consistent compliance with environmental standards for bio-waste disposal provides the company with a predictable operational backdrop.

SLN: Prakiraan wutah bathi resik saben saham ing taun ngarep Silence Therapeutics Inc. 21.06.2023 - 16.11.2026

Rincian analitis lan laporan data perusahaan Silence Therapeutics PLC (SLN)

Ringkesan analitik perusahaan:Silence Therapeutics PLC, SLN
Produk dadi Silence Therapeutics plc

Assessing the investment reliability of equity assets begins with an analysis of future return on equity. This metric measures the percentage deviation of expected earnings per share for the coming year from current values. For Silence Therapeutics (SLN), which lacks its own revenue streams and depends on partner payments, this calculation reflects only hypothetical scenarios for the commercialization of RNA therapy. The trend in expected EPS changes for the next year serves as an indicator of market confidence in the success of clinical trials.

Pesaing Silence Therapeutics

TEM (Tempus) - Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep QGEN (Qiagen)|Prakiraan wutah bathi kanggo taun ngarep IONS|RGEN (Repligen) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep aviditybiosciences.com RNA|CRISPR (CRSP) - Prakiraan wutah bathi resik saben saham ing taun ngarep|genedx.com - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep RARE (ultragenyx.com)|BEAM: Prakiraan wutah bathi kanggo taun ngarep|Sarepta - Dinamika bathi saben saham sing diarepake ing taun ngarep|TWST (twistbioscience.com) - Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep TXG (10x Genomics Corp)|Prakiraan wutah bathi kanggo taun ngarep NTLA|Prakiraan wutah bathi kanggo taun ngarep Stoke Therapeutics, Inc. (STOK)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioLife BLFS|WVE - Prakiraan wutah bathi saben saham kanggo taun ngarep|Maze Therapeutics Corp - Prakiraan wutah bathi kanggo taun ngarep|Sionna Pharma - Proyeksi tambahing bathi saben saham ing taun ngarep|Prime Medicine (PRME) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|tayshagtx.com (TSHA) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep uniQure Corp|MGTX: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep RGNX|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Solid Corp|Prakiraan wutah bathi kanggo taun ngarep OCGN (ocugen.com)|PACB (Pacific Biosciences) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Benitec Biopharma Inc - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|4D Molecular Therapeutics (FDMT) - Prakiraan wutah bathi kanggo taun ngarep|LXEO (Lexeo Therapeutics, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep korrobio.com KRRO|Prakiraan wutah bathi saben saham kanggo taun ngarep EDIT (Editas Medicine, Inc.)|PRQR: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CDXS (codexis.com)|SGMO: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|NAUT: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep metagenomi.co|Precision BioSciences, Inc. (DTIL) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Generation Bio Corp (GBIO)|Prakiraan wutah bathi saben saham kanggo taun ngarep BOLD|exicuretx.com (XCUR) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep IMNN (Celsion Corporation)|PHIO (Phio Pharmaceuticals Corp.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep MBIO (Mustang Bio Corp)|Proyeksi tambahing bathi saben saham ing taun ngarep RNAZ (TransCode Therapeutics)|BNGO - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|APDN: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|BLUE: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep ImmunoPrecise Antibodies|OMGA (Omega Therapeutics, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Singular Genomics (OMIC) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Regulus (RGLS)|SYRS (Syros Pharmaceuticals, Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Telesis Bio, Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|TCON: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Unity Biotechnology Inc. - Prakiraan wutah bathi kanggo taun ngarep